Description of microangiopathy in children with type 1 diabetes mellitus: A 19-year retrospective study

Diabetes and Metabolism

Volumn 29, Issue 4 I, 2003, Pages 395-402

  Bouhanick, B ^a,d   Raguin, H ^a   Rohmer, V ^a   Ebran, J M ^b   Simard, G ^b   Limal, J M ^c  

^a Service de Medecine B   (France)

^b Department of Ophthalmology ^*  (France)

^c Paediatric Department   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Diabetic Retinopathy; Metabolic Control; Microalbuminuria; Microangiopathy; Type 1 Diabetes Mellitus

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HORMONAL REGULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROALBUMINURIA; ONSET AGE; PREVALENCE; PUBERTY; RETROSPECTIVE STUDY; SEX DIFFERENCE;

EID: 0141509961     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70050-2     Document Type: Article

References (44)

1. Singer DE, Nathan DM, Fogel HA, Schachat AP. Screening for diabetic nephropathy. Ann Intern Med, 1992, 116, 660-1.
2. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care, 1998, 21, 143-56.
3. Trautner C, Haastert B, Giani G, Berger M. Incidence of blindness in southern Germany between 1990 and 1998. Diabetologia, 2001, 4, 147-50.
4. Janka HU, Warram JH, Rand LI, Krolewski AS. Risk factors for progression of background retinopathy in long-standing Type 1 diabetes. Diabetes, 1989, 38, 460-4.
5. Cohen RA, Hennekens CH, Christen WG, et al. Determinants of retinopathy progression in type 1 diabetes mellitus. Am J Med, 1999, 107, 45-51.
6. The DCCT Research group. The effect of intensive treatment of the diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-86.
7. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet, 1982, 1430-2.
8. Walker J, Close C, Jones S, et al. Glomerular structure in type 1 (insulin-dependent) diabetic patients with normo- and microalbuminuria. Kidney Int, 1991, 41, 741-8.
9. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia, 1983, 25, 496-501.
10. Marschall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child, 1969, 4, 291-303.
11. Marschall WA, Tanner JM. Variations in pattern of pubertal changes in boys. Arch Dis Child, 1970, 45, 13-23.
12. Early Treatment Diabetic Retinopathy Study Research group. Fundus photographic risk factors for progression of diabetic nephropathy. Ophthalmology, 1991, 92, 823-33.
13. Marre M, Claudel JP, Ciret P, Luis N, Suarez L, Passa P. Laser immunonephelometry for routine quantification of urinary albumin excretion. Clin Chem, 1987, 33, 209-13.
14. Bouhanick B, Berrut G, Chameau AM, et al. Predicting value of testing random urine sample to detect microalbuminuria in diabetic subjects during out patient visits. Diabetes Metab, 1992, 18, 54-8.
15. Fabiny DL, Eertingshausen G. Automated reaction rate method for determination of serum creatinine with the Centrichem. Clin Chem, 1971, 17, 696-700.
16. Chantler C, Garnett Es, Parsons V, Veall N. Glomerular filtration rate measurement in man by the single injection method using 51 Cr-EDTA. Clinical Science, 1969, 37, 169-75.
17. Marre M, Hallab M, Roy J, Le Jeune JJ, Jallet P, Fressinaud P. Glomerular hyperfiltration in type I, type II and secondary diabetes. J Diab Comp, 1992, 6, 19-24.
18. Bouhanick B, Gallois Y, Hadjadj S, Boux de Casson F, Limal JM, Marre M. Relationship between glomerular hyperfiltration and ECA Insertion/Deletion polymorphism in type 1 diabetic children and adolescents. Diabetes Care, 1999, 22, 618-22.
19. Weykamp CW, Penders TJ, Muskiet FAJ, Van der Slik W. Glycohaemoglobin: comparison of 12 analytical methods, applied to lyophilized haemolysates by 101 laboratories in an external quality assurance programme. Ann Clin Biochem, 1993, 30, 169-74.
20. Goldstein DE, Little RR, England JD, Wiedmeyer HM, McKensie EM. Methods for quantitating glycosylated hemoglobins: high performance liquid chromatography and thiobarbituric acid colorimetry. In Methods in diabetes research vol 2, clinical methods. Clarke WL, Larner J, Pohl SL, Eds. New York, Wileys, 1986, 475-504.
21. Schoenle EJ, Lang-Muritano M, Gschwend S, et al. Epidemiology of type 1 diabetes mellitus in Switzerland: steep rise incidence in under 5 year old children in the past decade. Diabetologia, 2001, 44, 286-9.
22. Pundziute-Lycka A, Dahlquist G, Nyström L, et al. The incidence of type 1 diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983 to 1998. Diabetologia, 2002, 45, 783-91.
23. Levy-Marschal C, Papoz L, Beaufort C, et al. Clinical and laboratory features of type 1 diabetic children at time of diagnosis. Diabetic Med, 1992, 9, 279-84.
24. The Diabetes Control and Complications trial research group. Effects of long-term complications in adolescents with insulin dependent diabetes mellitus. Diabetes Control and complications trial. J Pediatr, 1994, 125, 177-88.
25. Bryden KS, Dunger DB, Mayou RA, Peveler RC, Neil HAW. Poor prognosis of young adults with type 1 diabetes. Diabetes Care, 2003, 26, 1052-7.
26. Jackson RL, Ide CH, Guthrie RA, James RD. Retinopathy in adolescents and young adults with onset of insulin dependent diabetes in childhood. Ophthalmology, 1982, 89, 7-13.
27. Levin BS, Anderson BJ, Butler DA, Antisdel JE, Brackett J, Laffel LMB. Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. J Pediatr. 2001, 139, 197-203.
28. Chase HP. Glycemic control in prepubertal years. Diabetes Care, 2003, 26, 1304-5.
29. Burger W, Hovener G, Dusterus R, Hartmann R, Weber B. Prevalence and development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. A longitudinal study. Diabetologia, 1986, 29, 17-22.
30. Krowleski AS, Warram JH, Rand LI, Christlieb AR, Busick EJ, Kahn CR. Risk of proliferative diabetic retinopathy in juvenile onset type 1 diabetes: a 40-year follow-up study. Diabetes Care, 1986, 9, 443-52.
31. American Diabetes Association. Clinical practice recommendations 2000. Diabetes Care, 2000, 23, S730-76.
32. Donaghue KC, Fairchild JM, Craig ME, et al. Do all prepubertal years of diabetes duration contribute equally to diabetes complications? Diabetes Care, 2003, 26, 1224-9.
33. Rudberg S, Dahlquist G. Determinants of microalbuminuria in adolescents with Type 1 diabetes. Diabetes Care, 1996, 19, 369-71.
34. Lloyd CE, Stephenson J, Fuller JH, Orchard TJ. A comparison of renal disease across two continents. Diabetes Care, 1996, 19, 219-25.
35. Mattock MB, Cronin N, Cavallo-Perin P, et al. Plasma lipids and urinary albumin excretion rate in type 1 diabetes: The EURODIAB IDDM complications study. Diabet Med, 2001, 18, 59-67.
36. Schultz CJ, Konopelska-Bahu T, Dalton RN, et al. Microalbuminuria prevalence varies with age, sex and puberty in children with type 1 diabetes followed from diagnostic in a longitudinal study. Diabetes Care, 1999, 22, 495-502.
37. Rudberg S, Ullmann E, Dahlquist G. Relationship between early metabolic control and the development of microalbuminuria. A longitudinal study in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 1993, 36, 1309-14.
38. Donaghue KC, Fairchild JM, Chan A, Hing SJ, Howard NJ, Silink M. Diabetes complication screening in 937 children and adolescents. J Pediatr Endocrinol Metab, 1999, 12, 185-92.
39. Rudberg S, Aperia A, Freyschuss U, Persson B. Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia, 1990, 33, 470-6.
40. Hallab M, Gallois Y, Chatellier G, Rohmer V, Fressinaud P, Marre M. Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes. BMJ, 1993, 306, 175-82.
41. Lervang HH, Jensen J, Brochner-Mortensen J, Ditzel J. Early glomerular hyperfiltration and the later development of nephropathy in type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 1988, 31, 723-9.
42. Jones SL, Wiseman MJ, Viberti GC. Glomerular hyperfiltration as a risk factor for diabetic nephropathy: five year report of a prospective study. Diabetologia, 1991, 34, 59-65.
43. Yip JW, Jones SL, Wiseman MJ, Hill C, Viberti GC. Glomerular hyperfiltration in the prediction of nephropathy in IDDM. A 10 years follow-up study. Diabetes, 1996, 45, 1729-33.
44. Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy - An 8-year prospective study. Kidney Int, 1992, 4, 822-8.